Shopping Cart
- Remove All
Your shopping cart is currently empty
SLIGRL-NH2 TFA, also known as Protease-Activated Receptor-2 Activating Peptide TFA, is a Protease-Activated Receptor-2 (PAR-2) agonist [1].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks |
| Description | SLIGRL-NH2 TFA, also known as Protease-Activated Receptor-2 Activating Peptide TFA, is a Protease-Activated Receptor-2 (PAR-2) agonist [1]. |
| In vitro | SLIGRL-NH2 serves as an agonist for both PAR-2 and MrgprC11 [1]. It induces a relaxation that is inhibited by L-NAME, suggesting a nitric oxide-dependent mechanism. Importantly, SLIGRL-NH2 achieves a concentration-dependent relaxation with an EC50 of 10 µM in endothelium-free preparations when accompanied by perivascular adipose tissue (PVAT). Consequently, a concentration of 20 µM is selected for further experiments to assess the influence of inhibitors on ADRF release and activity. In endothelium-denuded aortic preparations, the peptide solely elicits this concentration-dependent relaxation in conjunction with PVAT [+PVAT, -ENDO (endothelium)] [2]. |
| Synonyms | Protease-Activated Receptor-2 Activating Peptide TFA |
| Molecular Weight | 770.84 |
| Formula | C31H57F3N10O9 |
| Cas No. | 2828432-39-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.